|
⚲
|
| Oceana Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001436455 |
| Sale | 2008-05-13 ($50.0 M Offered, $3.0 M Sold) |
| Fund | |
| Phone | 9738798240 |
| Address | 18 Garabrant Street Mendham, 07945 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2009-05-27 (D/A) |
| Exemption | 506 |
| Minimum | $16,770 |
| Remaining | $47,000,001 |
| Duration | More than one year |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Ryan Drant | Director | |
| Brian Halak | Director | |
| Robert More | Director | |
| John Spitznagel | Executive Officer | |
| Adele Oliva | Director | |
| Andrew Einhorn | Executive Officer | |
| David Tierney | Executive Officer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Advanced Technology Select Fund X LLC
✚
|
0.0 | |
|
Advanced Technology Select Fund XVII LLC
✚
|
0.0 | |
|
Advanced Technology Select Fund XVI LLC
✚
|
0.0 | |
|
Advanced Technology Select Fund XV LLC
✚
|
0.0 | |
|
Advent Global Technology II-A SCSp
✚
|
0.0 | |
|
Advent Global Technology II-B Limited Partnership
✚
|
0.0 | |
|
Advent Global Technology II-C Limited Partnership
✚
|
0.0 | |
|
Advent Global Technology II Limited Partnership
✚
|
0.0 | |
|
Advent Partners AGT II-C SCSp
✚
|
0.0 | |
|
Advanced Technology Select Fund XIV LLC
✚
|
0.0 |